Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 6, 2017Seminars in Thrombosis and Hemostasis

Risk Assessment Scores for Cancer-Associated Venous Thromboembolic Disease

View Full Paper
Ask AI
Bookmark
Share

Population

Patients with cancer

Design

Review

Authors

DADana E. AngeliniAKAlok A. Khorana

Discussion

Loading...

Member takes

Overview

May aid VTE risk stratification in cancer; leaves open prospective validation before practice change.

Structured PICO

P
Population
Patients with cancer
I
Intervention
Risk assessment scores for venous thromboembolism (VTE)
O
Outcome
Prediction of primary and recurrent cancer-associated VTE

Risk assessment tools are valuable for predicting primary and recurrent venous thromboembolism in patients with cancer.

Cite This Study

Angelini et al. (2017) studied this question.

synapsesocial.com/papers/6a21a304e06b4fc4c1abc4bfhttps://doi.org/10.1055/s-0036-1597281
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality2016 · 69 citations
  2. 2Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis2012 · 571 citations
  3. 3Predictors of Venous Thromboembolic Events Associated with Central Venous Port Insertion in Cancer Patients2014 · 35 citations
  4. 4Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study2011 · 100 citations
  5. 5High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis2011 · 434 citations